annamycin has been researched along with Acute Lymphoid Leukemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andreeff, M; Ford, LA; Heffner, TL; Kantarjian, HM; O'Brien, S; Parekh, S; Shepard, R; Thomas, DA; Wang, ES; Wetzler, M | 1 |
| Alvarado, Y; Apostolidou, E; Giles, FJ; Swords, R | 1 |
1 review(s) available for annamycin and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
Emerging therapeutic options for Philadelphia-positive acute lymphocytic leukemia.
Topics: Animals; Antineoplastic Agents; Doxorubicin; Fusion Proteins, bcr-abl; Glutamates; Guanine; Humans; Pemetrexed; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sulfonamides; Vincristine | 2007 |
2 trial(s) available for annamycin and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
Phase I/II trial of nanomolecular liposomal annamycin in adult patients with relapsed/refractory acute lymphoblastic leukemia.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Doxorubicin; Female; Humans; Liposomes; Male; Middle Aged; Nanoparticles; Neoplasm Grading; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Young Adult | 2013 |
Aronex Pharmaceuticals reports on annamycin phase I trial.
Topics: Acute Disease; Antibiotics, Antineoplastic; Doxorubicin; Heart; Humans; Leukemia, Myeloid; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2001 |